Sponsor or institution

Clinical trials and research at Servier

• 9Clinical trials
• 20Countries

Newest trials

All recruiting trials (9)

• Vorasidenib for kids with Grade 2 glioma that has IDH mutations

  This study tests whether vorasidenib is safe and helps control disease in kids aged 12 to 18 with Grade 2 astrocytoma or oligodendroglioma carrying an IDH mutation.

  Recruiting at 5 sites Phase 2 Servier · Los Angeles, California and 4 other locations · NCT07286292

• Vorasidenib pharmacokinetics in severe vs. normal liver function

  This study tests how a single 20 mg dose of vorasidenib behaves in people with severe liver impairment compared to those with normal liver function.

  Recruiting at 3 sites Phase 1 Servier · Chandler, Arizona and 2 other locations · NCT07250633

• S230815 for children with KCNT1-related developmental and epileptic encephalopathy

  This study will test whether the investigational medicine S230815 is safe, well tolerated, and affects seizures and related symptoms in children aged 2–12 who have KCNT1-related developmental and epileptic encephalopathy.

  Recruiting at 11 sites Phase 1/2 Servier · Orange, California and 14 other locations · NCT07227857

• Ivosidenib for adults with IDH1‑mutated cancers and liver or kidney impairment.

  This will test ivosidenib in adults with IDH1‑mutated cancers who have liver or kidney impairment to see how the drug is absorbed, processed, and tolerated.

  Recruiting at 17 sites Phase 1 Servier · Atlanta, Georgia and 19 other locations · NCT07006688

• Treatment for Myelodysplastic Syndromes with IDH1 Mutation

  This study is testing whether a new drug called ivosidenib can help people with myelodysplastic syndromes and an IDH1 mutation feel better compared to the standard treatment with azacitidine.

  Recruiting at 57 sites Phase 3 Servier · Denver, Colorado and 61 other locations · NCT06465953

• Ivosidenib for advanced or metastatic chondrosarcoma with IDH1 mutation

  This study is testing if a new pill called ivosidenib can help people with advanced chondrosarcoma that has an IDH1 mutation live longer and feel better compared to a placebo.

  Recruiting at 111 sites Phase 3 Servier · Los Angeles, California and 114 other locations · NCT06127407

• Treatment for adults with IDH1 mutation-positive acute myeloid leukemia who can't undergo intensive chemotherapy

  This study is testing if a combination of two medications can help adults with a specific type of leukemia who can't have strong chemotherapy.

  Recruiting at 10 sites Phase 3 Servier · Vienna and 14 other locations · NCT05907057

• Evaluating BDTX-4933 for patients with specific cancer mutations

  This study is testing a new drug called BDTX-4933 to see if it can help adults with advanced cancers that have certain gene mutations feel better and improve their treatment options.

  Recruiting at 34 sites Phase 1/2 Servier · Gilbert, Arizona and 48 other locations · NCT05786924

• Evaluating AG-120 for patients with advanced blood cancers and IDH1 mutations

  This study is testing a new drug called AG-120 to see if it can help people with advanced blood cancers that have a specific IDH1 mutation feel better and live longer.

  Recruiting at 6 sites Phase 1 Servier · Birmingham, Alabama and 29 other locations · NCT02074839

Quick answers

How many clinical trials run by Servier are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 20 countries. The most sites are in United States (8 trials), France (6 trials), Italy (5 trials), Spain (5 trials), Australia (5 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 1: 3, Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →